261 related articles for article (PubMed ID: 30814999)
1. Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1.
Rossowska J; Anger N; Wegierek K; Szczygieł A; Mierzejewska J; Milczarek M; Szermer-Olearnik B; Pajtasz-Piasecka E
Front Immunol; 2019; 10():211. PubMed ID: 30814999
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy.
Rossowska J; Anger N; Szczygieł A; Mierzejewska J; Pajtasz-Piasecka E
J Exp Clin Cancer Res; 2018 Jun; 37(1):126. PubMed ID: 29954431
[TBL] [Abstract][Full Text] [Related]
4. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
Conroy H; Galvin KC; Higgins SC; Mills KH
Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells.
Rossowska J; Anger N; Szczygieł A; Mierzejewska J; Pajtasz-Piasecka E
Front Immunol; 2017; 8():713. PubMed ID: 28713366
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma.
Szczygieł A; Węgierek-Ciura K; Wróblewska A; Mierzejewska J; Rossowska J; Szermer-Olearnik B; Świtalska M; Anger-Góra N; Goszczyński TM; Pajtasz-Piasecka E
Front Immunol; 2023; 14():1155377. PubMed ID: 37033926
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model.
Huang F; Wan J; Hao S; Deng X; Chen L; Ma L
Cancer Immunol Immunother; 2017 Oct; 66(10):1321-1331. PubMed ID: 28601924
[TBL] [Abstract][Full Text] [Related]
8. Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment.
Jiang L; Fei H; Yang A; Zhu J; Sun J; Liu X; Xu W; Yang J; Zhang S
Cancer Lett; 2021 Nov; 520():332-343. PubMed ID: 34391809
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression.
Yamada N; Kuranaga Y; Kumazaki M; Shinohara H; Taniguchi K; Akao Y
Oncotarget; 2016 May; 7(19):27033-43. PubMed ID: 27081032
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles.
Liu J; Ma J; Tang K; Huang B
Methods Mol Biol; 2017; 1660():433-440. PubMed ID: 28828677
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.
Wei H; Liu P; Swisher E; Yip YY; Tse JH; Agnew K; Hellström KE; Hellström I
J Immunother; 2012 Apr; 35(3):267-75. PubMed ID: 22421944
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells stimulated with cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively reduce outgrowth of established tumors in vivo.
Hiraide A; Hiroishi K; Eguchi J; Ishii S; Doi H; Imawari M
Cancer Sci; 2008 Aug; 99(8):1663-9. PubMed ID: 18754881
[TBL] [Abstract][Full Text] [Related]
13. Generation of anti-tumor response by JAWS II mouse dendritic cells transduced with murine interleukin 12 genes.
Pajtasz-Piasecka E; Rossowska J; Szyda A; Krawczenko A; Dus D
Oncol Rep; 2007 May; 17(5):1249-57. PubMed ID: 17390073
[TBL] [Abstract][Full Text] [Related]
14. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
15. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-β1 can kill carcinoma cancer cells.
Chulpanova DS; Gilazieva ZE; Akhmetzyanova ER; Kletukhina SK; Rizvanov AA; Solovyeva VV
Tissue Cell; 2021 Dec; 73():101664. PubMed ID: 34678531
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA.
Oh S; Kim E; Kang D; Kim M; Kim JH; Song JJ
Cancer Gene Ther; 2013 Feb; 20(2):94-100. PubMed ID: 23306609
[TBL] [Abstract][Full Text] [Related]
17. Temporary elimination of IL-10 enhanced the effectiveness of cyclophosphamide and BMDC-based therapy by decrease of the suppressor activity of MDSCs and activation of antitumour immune response.
Rossowska J; Anger N; Kicielińska J; Pajtasz-Piasecka E; Bielawska-Pohl A; Wojas-Turek J; Duś D
Immunobiology; 2015 Mar; 220(3):389-98. PubMed ID: 25454807
[TBL] [Abstract][Full Text] [Related]
18. Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer.
Florencia Soler M; Del Carmen Bravo-Miana R; María Negretti-Borga D; Subirada P; Alejandra Alamino V; Cecilia Sánchez M; Carolina Donadio A; Gabriela Pellizas C; Del Mar Montesinos M
Int Immunopharmacol; 2022 Sep; 110():109016. PubMed ID: 35978502
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
Eguchi J; Hiroishi K; Ishii S; Mitamura K
Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
